Search results for " pharmacy"

showing 10 items of 365 documents

Tolmetin-Induced Esophageal Ulceration

1997

medicine.medical_specialtybusiness.industry030204 cardiovascular system & hematologyEsophageal ulceration030226 pharmacology & pharmacyGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineTolmetinPharmacology (medical)businessmedicine.drugAnnals of Pharmacotherapy
researchProduct

Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations

2016

Bariatric surgery is the most effective solution for severe obesity and obesity with comorbidities, and the number of patients going through bariatric surgery is rapidly and constantly growing. The modified gastrointestinal anatomy of the patient may lead to significant pharmacokinetic alterations in the oral absorption of drugs after the surgery; however, because of insufficient available literature and inadequate awareness of the medical team, bariatric surgery patients may be discharged from the hospital with insufficient instructions regarding their medication therapy. In this article, we aim to present the various mechanisms by which bariatric surgery may influence oral drug absorption…

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismPublic Health Environmental and Occupational HealthSevere obesity030226 pharmacology & pharmacyEffective solutionSurgery03 medical and health sciences0302 clinical medicinemedicineMedical team030212 general & internal medicinebusinessOral retinoidObesity Reviews
researchProduct

Risk Factors for Secondary Cancer in a Case-Control Study on 1,259 Patients with Myeloproliferative Neoplasms

2018

Abstract INTRODUCTION The incidence of secondary cancer (SC) in patients with myeloproliferative neoplasms (MPN) is high and comparable to that of thrombosis. However, the identification of patient subgroups that might be at increased susceptibility of developing SC has not been systematically addressed. We report here the results of an international case-control study (MPN-K) aimed at comparing the frequency of exposure to possible causes of SC in patients with classical MPN, polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF). METHODS This European Leukaemia Network (ELN) study reports MPN patients from 28 sites of 5 European countries and Israel, diagnosed in th…

medicine.medical_specialtybusiness.industryEssential thrombocythemiaPipobromanIncidence (epidemiology)ImmunologyCase-control studyCancerCell BiologyHematologymedicine.disease030226 pharmacology & pharmacyBiochemistryGastroenterology03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineMedicineRisk factorSkin cancerbusinessMyelofibrosismedicine.drugBlood
researchProduct

Haemoperfusion: a useful therapy for a severely poisoned patient?

1986

Although it is many years since a haemodialysis and haemoperfusion over uncoated and later coated charcoal columns have been used for the treatment of intoxicated patients, the clinical efficacy of these extracorporeal techniques in the treatment of severely poisoned patients remains a matter of debate. Some of the reasons for this controversy may be the indiscriminate use of haemoperfusion in any form of intoxication, the lack of well-controlled studies and the wrong interpretation of the high haemoperfusion clearance values sometimes obtained. Simple pharmacokinetic principles are applied to this type of treatment and some practical guidelines as to how and when haemoperfusion should be …

medicine.medical_specialtybusiness.industryHealth Toxicology and Mutagenesismedicine.medical_treatmentPoisoningToxicologyHemoperfusion030226 pharmacology & pharmacyModels BiologicalExtracorporealHemoperfusion03 medical and health sciences0302 clinical medicineRenal DialysismedicineHumans030212 general & internal medicineClinical efficacyIntensive care medicinebusinessForecastingHuman toxicology
researchProduct

Role of the hospital pharmacist in an Italian antimicrobial stewardship programme

2020

The inappropriate use of antimicrobial agents is contributing to an increasing phenomenon of bacterial resistance. For this reason, there is a growing interest in ‘antimicrobial stewardship’, a series of coordinated and multidisciplinary interventions aimed to promote the safe and appropriate use of antimicrobials in which the pharmacist’s contribution is necessary for the optimal choice of drug, dose, duration of therapy and the implementation of cost containment strategies. AIM OF THE STUDY: We wanted to create a reference model and a specific training manual on antibiotic stewardship to introduce the role of the department pharmacist with specific infection disease skills in the Italian …

medicine.medical_specialtybusiness.industryPsychological interventionPharmacistTraining manualPharmacistsCommunicable Diseases030226 pharmacology & pharmacyHospitalsClinical pharmacyAntimicrobial Stewardship03 medical and health sciences0302 clinical medicineAnti-Infective AgentsFamily medicinemedicineHumansInfection controlAntimicrobial stewardship030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsHospital pharmacybusinessAdverse effectOriginal ResearchEuropean Journal of Hospital Pharmacy
researchProduct

STUDY OF LIFE QUALITY AND TREATMENT SATISFACTION OF ROMANIAN DIABETIC PATIENTS

2019

In Romania, antidiabetic medication is free, based on a program of the Ministry of Public Health: “Treatment of patients with diabetes mellitus”. Since October 1, 2006, antidiabetic drugs have been delivered through open circuit pharmacies in contractual relationship with the National Health Insurance House, after four years of centralized delivery through hospital pharmacies.
 Objectives: This study aims to describe the influences of the diabetes treatment regarding patients’ quality of life and their satisfaction.
 Methods: A cross-sectional descriptive study was performed in pharmacies. The study includes 477 patients with diabetes mellitus from Cluj County, Romania. The interv…

medicine.medical_specialtybusiness.industryPublic healthLife qualityOcean EngineeringPharmacymedicine.diseasePatient satisfactionQuality of lifeDiabetes mellitusFamily medicineLife expectancyMedicineHospital pharmacybusinessCBU International Conference Proceedings
researchProduct

Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes

2014

Objective The purpose of this study was to evaluate the contamination rate of media-fill products either prepared automated with a robotic system (APOTECAchemo™) or prepared manually at cytotoxic workbenches in the same cleanroom environment and by experienced operators. Media fills were completed by microbiological environmental control in the critical zones and used to validate the cleaning and disinfection procedures of the robotic system. Methods The aseptic preparation of patient individual ready-to-use injection solutions was simulated by using double concentrated tryptic soy broth as growth medium, water for injection and plastic syringes as primary packaging materials. Media fills w…

medicine.medical_specialtybusiness.industrySyringesRoboticsCleaning validation030226 pharmacology & pharmacySurgeryPharmaceutical Solutions03 medical and health sciencesContamination rate0302 clinical medicineRobotic systemsOncologyTechnology PharmaceuticalMedicinePharmacology (medical)030212 general & internal medicineAseptic processingDrug ContaminationbusinessAsepsisBiomedical engineeringJournal of Oncology Pharmacy Practice
researchProduct

The evolution of European Medicines Agency drug approval: the adaptive licensing: Table 1

2015

In March 2014, the European Medicines Agency (EMA) launched a pilot project of ‘adaptive licensing’ to speed up access to drugs in development, in order to respond to unmet medical needs. The project will involve parallel scientific advice from the regulatory agency, pharmaceutical industry, the companies Health Technology Assessment (HTAs) bodies, organisations studying guidelines on clinical treatment and patient associations. The traditional process of drug authorisation is divided into several parts, involving in vitro studies and in vivo studies in animals (preclinical studies), as well as phase 1–3 randomised controlled trials conducted in humans over a predefined period. When authori…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationHealth technology030226 pharmacology & pharmacyClinical pharmacyTransplantation03 medical and health sciences0302 clinical medicineNursing030220 oncology & carcinogenesisFamily medicinePharmacovigilanceMedicineObservational studyGeneral Pharmacology Toxicology and PharmaceuticsbusinesseducationAdverse effectPharmaceutical industryEuropean Journal of Hospital Pharmacy
researchProduct

Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review.

2020

The Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe, multiorganic, and potentially life-threatening drug-induced hypersensitivity reaction, linked to several common drugs, including antiepileptics, antibiotics, and several psychotropic drugs, including clozapine. Due to the importance of clozapine in the management of treatment-resistant schizophrenia, a systematic review and characterization of clozapine-related DRESS syndrome is long overdue.This systematic review was conducted following PRISMA guidelines. PubMed, Embase, PsychINFO, and the Cochrane Library databases were independently reviewed up to 1 November 2019 for articles reporting clozapine-relat…

medicine.medical_specialtymedicine.medical_treatmentmacromolecular substances030226 pharmacology & pharmacyDrug reaction with eosinophilia and systemic symptoms03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesMedicineHumansPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsAntipsychoticClozapineClozapinebusiness.industrymusculoskeletal neural and ocular physiologyGeneral Medicinemedicine.diseaseDermatologyHypersensitivity reactionnervous system030220 oncology & carcinogenesisDrug Hypersensitivity SyndromePolypharmacySchizophreniabusinessmedicine.drugAntipsychotic AgentsExpert review of clinical pharmacology
researchProduct

Clinical implications ofCYP3Apolymorphisms

2006

Due to their enormous substrate spectrum CYP3A4, -3A5 and -3A7 constitute the most important drug-metabolising enzyme subfamily in humans. CYP3As are expressed predominantly, but not exclusively, in the liver and intestine, where they participate in the metabolism of 45 - 60% of currently used drugs and many other compounds such as steroids and carcinogens. CYP3A expression and activity vary interindividually due to a combination of genetic and nongenetic factors such as hormone and health status, and the impact of environmental stimuli. Over the past several years, genetic determinants have been identified for much of the variable expression of CYP3A5 and -3A7, but not for CYP3A4. Using th…

medicine.medical_treatmentBiologyToxicologyBioinformatics030226 pharmacology & pharmacyGene Expression Regulation EnzymologicTacrolimusVariable Expression03 medical and health sciencesProstate cancer0302 clinical medicinemedicineCytochrome P-450 CYP3AHumansCYP3A5PharmacologyRegulation of gene expressionGeneticsPolymorphism GeneticCYP3A4General Medicinemedicine.diseaseTacrolimus3. Good healthIsoenzymesImmunosuppressive drug030220 oncology & carcinogenesisCyclosporineImmunosuppressive AgentsPharmacogeneticsExpert Opinion on Drug Metabolism & Toxicology
researchProduct